NanoSignals: Nanotechnology
for Precision Diagnostics

The simplicity of an ELISA, with the sensitivity of a molecular test.

Our History

Cutting-edge science transforming realities

Born in the laboratories of the Federal University of Minas Gerais (UFMG), NanoSignals was consolidated through a solid track record of over 15 years of continuous scientific research and development in the field of diagnostic nanotechnology. 

 

Our technology utilizes gold nanorods and the Localized Surface Plasmon Resonance (LSPR) phenomenon to detect analytes at femtomolar concentrations. The robustness of this method is backed by scientific articles published in high-impact international journals and a portfolio of national and international patents, both granted and pending. 

 

Today, as a biotechnology spin-off (deep tech), we operate in translational research to structure and validate high-precision in vitro diagnostic products.

The NanoSignals Advantage

Ultrasensitive LSPR Detection

Our technology is based on the use of functionalized gold nanorods. Through localized surface plasmon resonance (LSPR), we identify target molecules at concentrations that traditional methods cannot reach.

Femtomolar Sensitivity

Ability to detect diseases and contaminants at very early stages with molecular-level precision, saving lives and resources.

Operational Simplicity

Drastic reduction in operational steps. Readings performed on standardized equipment (microplate readers), with no need for high CAPEX.

Highly Selective

Zero false positives. Our markers bind exclusively to target molecules (such as the Dengue, Zika, or Yellow Fever viruses).

Our Publications

Want to know more
about NanoSignals?

Download our institutional e-book and learn about our market vision

Our Partners

Where We Are

NanoSignals was born and operates out of one of Brazil's largest innovation hubs, the Federal University of Minas Gerais.

Contact Us

Fill out the form below for questions, partnerships, or business inquiries.